We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
-1.43%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$587M
AUM Growth
-$12.4M
Cap. Flow
+$16.1M
Cap. Flow %
2.74%
Top 10 Hldgs %
100%
Holding
6
New
Increased
2
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 58.14%
2 Consumer Staples 36.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNST icon
1
Monster Beverage
MNST
$94.3B
$214M 36.5%
9,594,816
MNK
2
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$191M 32.47%
1,619,968
STAA icon
3
STAAR Surgical
STAA
$1.21B
$78.4M 13.35%
8,117,582
+700,000
+9% +$6.49M
LCTX icon
4
Lineage Cell Therapeutics
LCTX
$269M
$64.7M 11.02%
22,095,035
CYNO
5
DELISTED
Cynosure, Inc. Class A
CYNO
$31.5M 5.37%
817,029
AST
6
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$7.55M 1.29%
1,641,025
+1,000,000
+156% +$9.59M

Similar funds

Broadwood Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Broadwood Capital held 6 positions worth $587M, down 2.1% from $600M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2015: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 59% a quarter earlier, followed by Consumer Staples.

  • Broadwood Capital added most to Asterias Biotherapeutics Inc. Series A in Q2 2015, an estimated $9.59M increase.
  • Broadwood Capital's ten largest holdings make up 100% of its $587M portfolio in Q2 2015.
  • Broadwood Capital opened 0 new positions and closed 0 in Q2 2015.
  • Broadwood Capital's portfolio value fell 2.1% quarter-over-quarter to $587M.

Based on Broadwood Capital's 13F filing for Q2 2015, filed 14 Aug 2015.